BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced that it has posted a bond, as authorized by the Munich Higher Regional Court, in order to suspend an injunction ...

Xenium In Situ demonstrates higher transcript counts per gene in new comparison study of three spatial imaging platforms PLEASANTON, Calif., Dec. 13, 2023 /PRNewswire/ -- 10x Genomics, Inc. (TXG) ...

Many biological functions and systems are influenced by how gene expression is spatially distributed, from subcellular through to tissue, organ, or at embryonic level. Our understanding of these ...

When NanoString Technologies—a pioneering spatial biology company in Seattle—filed for bankruptcy in February this year, the future of the company and its technology remained unknown. Although Joe ...

Bruker Corporation BRKR recently announced the formation of a new division, Bruker Spatial Biology, to offer the most diverse and comprehensive solutions for spatial biology. It operates coordination ...

While the spatial genomics segment was expanding at fastest rate, the spatial transcriptomics segment accounted for the biggest proportion in 2023. Further segmentation of spatial transcriptomics ...

This figure shows how the STAIG framework can successfully identify spatial domains by integrating image processing and contrastive learning to analyze spatial transcriptomics data effectively.

Spatial transcriptomics is a technique that provides information about gene expression patterns within intact tissues. This technology employs various methodologies, including in situ sequencing (ISS) ...

I initiate Bruker with a 'Hold' rating and a fair value of $43 per share due to near-term growth challenges. FY25 growth is pressured by weak academic research funding and tariff uncertainties, ...